Beau Ances (Washington University in St Louis, MO, USA) discusses recent research on amyloid biomarkers in people with genetic forms of Alzheimer’s disease; his Article is published in the January issue of The Lancet Neurology.
Read the full article:
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease
Continue this conversation on social!
Follow us today at...